Dementia research funding must triple, say experts

The Alzheimer's Research Trust and Alzheimer's Society revealed that the UK government lags behind France, Germany and the US in dementia research funding and has no plans for the future. They called on the government to exploit the UK's huge scientific talent and lead the world in the race for a cure.

In a joint statement launched ahead of the government's forthcoming Dementia Research Summit due to take place this summer, the charities set out priorities and opportunities for dementia research. Significant opportunities in dementia research include improving diagnosis, genetic research, improving care, and utilising the NHS in clinical trials.

Neil Hunt, Chief Executive of Alzheimer's Society, says,

'Dementia is the health challenge of our generation, it is absolutely vital that dementia research funding is tripled. One million people will develop dementia in the next ten years, yet the government invests just 2% of its medical research budget on dementia.

The Dementia Research Summit must be more than just a talking shop. It is a crucial opportunity for the government, charities and stakeholders to commit to a shared vision for dementia research. We need an ambitious plan that drives change and defeats this devastating condition.'

Rebecca Wood, Chief Executive of the Alzheimer's Research Trust, says,

'700,000 people in the UK live with dementia, costing our economy £17 billion annually. Given the stakes, the government cannot afford to get its dementia research policy wrong.

'Spending £96 million per year would put the UK proportionately on a par with other world-leaders like the United States, and bring funding per person with dementia up to a similar level to government investment in cancer research.'